MCT2D at the 2023 American Diabetes Association Scientific Sessions
Members of the MCT2D leadership and coordinating center present at the American Diabetes Association 83rd Scientific Sessions, June 23-26, 2023.
Unequal Barriers to CGM Implementation
Katherine Khosrovaneh, MPH, data analyst for MCT2D, and lead author, presented an ePoster on behalf of the MCT2D team, Impact of Social Vulnerability on Resources for CGM Initiation across Michigan Primary Care Practices, results from a survey of 169 MCT2D primary care practice providers (link).
Is Low Carb Enough?
Noa Kim, MSI, Informatics Design Lead, and Katherine also presented qualitative analysis of 375 MCT2D case summaries, on physician perceived benefit of multiple interventions versus low carb dietary education alone in the management of type 2 diabetes (link).
A Presidential Address
Rodica Pop-Busui, MD, PhD, MCT2D endocrinology content expert, delivered the president's address at ADA2023. Dr. Pop-Busui sharing her journey, from growing up in Timisoara, Romania, to coming to the United States nearly 30 years ago for a post doctoral research fellowship at the University of Michigan. She has gone on practice medicine as a board-certified endocrinologist and diabetes specialist, while leading pivotal clinical trials in diabetes care.
Dr. Busui served as lead, co-author, collaborator, and mentor for several ADA sessions, including:
- LX9211, an Orally-Administered, Non-opioid, AAK1 Inhibitor for Painful Diabetic Peripheral Neuropathy—Results from a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study (link)
- Association between Initial Outpatient Diabetic Foot Ulcers Infection Management Strategy and Hospitalization (link)
Dr. Pop-Busui is the Larry D. Soderquist Professor in Diabetes at the University of Michigan Medical School and President of Medicine and Science at the American Diabetes Association and is a foremost expert in the chronic complications of diabetes, particularly diabetic neuropathy, diabetic foot complications, diabetic kidney disease and cardiovascular disease, and novel technologies.
MCT2D content expert and obesity medicine physician Dr. Dina Hafez Griauzde, MD, MSc, discussed and debated low carb eating patterns in a debate-style session, entitled "Should We Curb the Carbs?" She also authored several presentations:
- Weight Status, Longitudinal Weight Change, and Weight Loss Treatment Utilization among Primary Care Patients with Obesity (link)
- Designing and Testing a Novel Weight Navigation Program to Improve Obesity Treatment in Primary Care Settings (link)
Recent news posts
september-2023-dexcom-educational-webinars
9/19/2023
PO Monthly Digest (Sept 2023)
8/31/2023
MCT2D August 2023 Newsletter
8/30/2023
Low Carb in the Community: MCT2D goes BREADLESS
8/30/2023
Updated BCBSM Prior Authorization Criteria to Ensure Access to GLP-1 RAs for Patients with Type 2 Diabetes
8/28/2023
